SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ISGTF or ISO Toronto shares traded 400,000 shares May 24

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Sultan who wrote (67)9/10/1998 10:33:00 AM
From: Link Lady  Read Replies (1) of 112
 
Earnings report out + buyback of shares
fin-info.com

ISG today is a growth company with positive cash flow, mounting
revenues, no debt, $ 20 million in cash, a lengthening roster of
products and clients, and a $ 41 million order backlog, " says
Michael M. Greenberg, MD, Chairman and Chief Executive Officer of
ISG. "Although we are pleased with this progress, it is a
stepping stone from which ISG must now press on to accelerated
earnings."

Normal Course Issuer Bid Planned

ISG is planning a normal course issuer bid via The Toronto Stock
Exchange to purchase up to 500,000 common shares over a one-year
period commencing September 30.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext